This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

URAC Names WellPoint’s Chief Medical Officer As Winner Of Health Care Stars!

URAC, a national accreditation and education leader, recognized WellPoint Chief Medical Officer Sam Nussbaum with its Health Care Stars! Award granted to those who demonstrate a commitment to saving and improving people’s lives and preventing adverse health outcomes.

“Individuals who choose to work in health care have a rare dedication to improving the lives of others,” said Kylanne Green, URAC president and CEO. “We are honored to showcase a select few who have constantly risen above their daily duties. These exceptional people do great work to protect and empower health care consumers worldwide.”

An innovator of provider payment strategy, Nussbaum, executive vice president of WellPoint’s Clinical Health Policy, advocates a national policy that shifts from rewarding volume to rewarding value. He is an internal champion of WellPoint’s commitment to transforming the private payment system for hospitals and physicians. His advocacy led WellPoint to become the first major health benefits company to announce in May 2011 that its affiliated health plans will only consider rate increases for hospitals willing to tie payments to improved safety, quality, patient care and value.

Nussbaum has led the building of Patient Centered Medical Homes across the nation, and he was a driving force behind Patient Safety First, a California health initiative partnership that has saved lives, improved care quality and reduced costs in California’s hospitals. The partnership contributed to saving more than 950 lives between 2010 and 2012.

URAC’s 2013 Health Care Stars! Awards were open to anyone who works for the more than 600 organizations that have earned or are in the process of earning URAC accreditation. The awards were judged by a panel of health care industry experts including URAC advisory committee members, board members and key leaders from across the industry. The panel reviewed all of the nominations, looking for specific accomplishments and clear results that the nominee had made a positive impact on the health of the consumers they serve.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,052.01 -180.01 -0.99%
S&P 500 2,106.33 -19.73 -0.93%
NASDAQ 5,033.6760 -55.6860 -1.09%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs